Alcon Inc. has proposed the acquisition of STAAR Surgical Company. Broadwood Partners, a major shareholder of STAAR, has voiced strong opposition to the proposed deal, criticizing both the process and the terms. Broadwood, which holds a 27.5% stake in STAAR, argues that the transaction undervalues the company and alleges that communications related to the deal have included misleading statements about STAAR's business prospects. The shareholder also highlighted significant negative feedback from other investors and proxy advisors regarding the proposed deal. Broadwood asserts that the STAAR Board should not delay the shareholder vote on the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251104591082) on November 04, 2025, and is solely responsible for the information contained therein.